For research use only. Not for therapeutic Use.
Arnicolide D(CAT: I018389) is a natural compound derived from Centipede minima. It exhibits various pharmacological activities and has shown potential as an anticancer agent. Arnicolide D modulates the cell cycle, induces apoptosis through the activation of the caspase signaling pathway, and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. It has been found to inhibit the viability of Nasopharyngeal carcinoma (NPC) cells in a concentration- and time-dependent manner. The multifaceted effects of Arnicolide D make it a promising candidate for further research and development in the field of cancer therapeutics.
Catalog Number | I018389 |
CAS Number | 34532-68-8 |
Molecular Formula | C₁₉H₂₄O₅ |
Purity | ≥95% |
Target | Caspase; PI3K; Akt; mTOR; STAT |
Reference | [1]. Liu R, et al. Arnicolide D, from the herb Centipeda minima, Is a Therapeutic Candidate against Nasopharyngeal Carcinoma. Molecules. 2019 May 17;24(10). |